Author:
Dronda F.,Alonso-Sanz M.,Laguna F.,Chaves F.,Martínez-Suárez J. V.,Rodríguez-Tudela J. L.,González-López A.,Valencia E.
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Microbiology (medical),General Medicine
Reference34 articles.
1. Como JA, Dismukes WE: Oral azole drugs as systemic antifungal therapy. New England Journal of Medicine 1994, 330: 263–272.
2. Troke PF, Andrews RJ, Pye GW, Richardson K: Fluconazole and other azoles: translation of in vitro activity to in vivo and clinical efficacy. Reviews of Infectious Diseases 1990, 12, Supplement 3: 276–280.
3. Brammer KW, Farrow PR, Faulkner JK: Pharmokinetics and tissue penetration of fluconazole in humans. Reviews of Infectious Diseases 1990, 12, Supplement 3: 318–326.
4. Wingard JR, Merz WG, Rinaldi MG, Johnson TR, Karp JE, Saral R: Increase inCandida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. New England Journal of Medicine 1991, 325: 1274–1277.
5. Persons DA, Laughlin M, Tanner D, Perfect J, Gockerman JP, Hathorn JW: Fluconazole andCandida krusei fungemia. New England Journal of Medicine 1991, 325: 1315.
Cited by
42 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献